LIPID MEASUREMENTS IN THE MANAGEMENT OF CARDIOVASCULAR DISEASES: PRACTICAL RECOMMENDATIONS

Emory University School of Medicine; Atlanta Veterans Affairs Medical Center; Johns Hopkins University School of Medicine; St. David’s Medical Center; University of Chicago School of Medicine; Centers for Disease Control and Prevention; Rigshospitalet,

The scientific statement reviews the pre-analytical, analytical, post-analytical, and clinical aspects of lipoprotein measurements. It emphasizes the importance of screening with non-fasting lipids and the reliability of non-HDL cholesterol in guiding ASCVD prevention. The document also discusses the clinical utility of measuring lipoprotein(a) and its implications for patient management, particularly in high-risk populations.